The new 300µL interlocked robotic arm machine (RAM) vial with 9mm thread finish from J G Finneran Associates based in Vineland, NJ, US is aimed at researchers tasked with managing a high number of chromatography sample vials in their laboratories.
Composed of a clear or amber Type I borosilicate glass, the vial and insert are fused together keeping the insert permanently in place. This enables accurate automated injection and eliminates contamination risk around the seam or space between the neck of the vial and the insert. The interlocked RAM vial arrives ready to use saving valuable time in the laboratory.
The vial has been designed to work in robotic arm autosamplers such as those available from Agilent Technologies and others. Robotic arms can easily grasp the 12mm x 32mm outer dimensions of the vial. Chromatography samples are contained in a clear Type I borosilicate glass 300µL conical tip insert. The interlocked RAM vial includes a marking spot, which can be written on with a #2 pencil. The vial is also available with a 9mm screw thread closure.
Interlocked RAM vial provides safe sample containment
For researchers managing a high number of chromatography sample vials
You may also like
Manufacturing
IMA MED-TECH launches ASSEMBLA modular assembly platform for medical devices across full lifecycle
Read moreThe engineer-to-order system scales from 20 to 500+ parts per minute on a single extendable frame, supporting injectables, inhalers, diagnostics and wearables from clinical trials through high-volume industrial production
Trending Articles
You may also like
Manufacturing
IMA MED-TECH launches ASSEMBLA modular assembly platform for medical devices across full lifecycle
The engineer-to-order system scales from 20 to 500+ parts per minute on a single extendable frame, supporting injectables, inhalers, diagnostics and wearables from clinical trials through high-volume industrial production
Manufacturing
Symeres expands spray drying capabilities at Cranbury CMC site for poorly soluble drug candidates
The investment integrates ASD development, formulation sciences, and analytical characterisation under one roof — supporting BCS Class II and IV compounds from preclinical screening through to Phase II clinical materials
Manufacturing
Reacta Healthcare secures expanded MHRA GMP certification covering in-house analytical testing
The renewed licence strengthens the OFC material manufacturer's quality oversight across its clinical trial supply chain, reinforcing its position as the only pharmaceutical GMP-compliant oral food challenge supplier operating globally
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months